ArticleTargeted oncology2018

Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.

Kazuhiro Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.